Recruiting Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma NCT06831175 Conditions Adenocarcinoma, Adrenal Cancer, Adrenal Cortex Diseases, +13 more Locations West China Hospital — Chengdu, Sichuan, China View Trial Details
Recruiting Assessment of Metabolic Complications in Patients With Adrenal Tumors Through Radiological Images NCT06801340 Conditions Adrenal Cancer, Adrenal Gland Diseases, Adrenal Gland Neoplasms, +4 more Locations IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy View Trial Details
Completed The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 Conditions Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more Locations Teton Cancer Institute — Idaho Falls, Idaho, United States Oncology and Hematology of South Texas — Laredo, Texas, United States View Trial Details
Completed Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer NCT01185639 Conditions Adrenal Cancer, Adrenal Gland Diseases, Adrenal Gland Neoplasms, +25 more Locations Coastal Carolina Radiation Oncology — Wilmington, North Carolina, United States Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States View Trial Details
Completed Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma NCT01898715 Conditions ACC, Adenocarcinoma, Adrenal Cancer, +12 more Locations Moffitt Cancer Center — Tampa, Florida, United States National Institutes of Health/National Cancer Institute — Bethesda, Maryland, United States University of Michigan Cancer Center — Ann Arbor, Michigan, United States MDAnderson Cancer Center — Houston, Texas, United States View more locations Show fewer locations Loading locations... View Trial Details
